Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases

Stine, Jonathan G., Wentworth, Brian J., Zimmet, Alex, Rinella, Mary E., Loomba, Rohit, Caldwell, Stephen H., Argo, Curtis K.·2018·Alimentary Pharmacology & Therapeutics
DOI 10.1111/apt.14937

Cited by (336)

Items 301–336 of 336

  1. Comentario editorial sobre carcinoma hepatocelular en hígado no cirrótico: características clínicas y resultados en Veracruz, México
    Carlos Moctezuma‐Velázquez · 2020 · Revista de Gastroenterología de México
  2. ULYSSES S. GRANT: The Unlikely Hero
    Paul L. Hulse · 2005 · Military review
  3. To study the risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease in central India
    Ankita A. Kondhalkar, Ranjit Sidram Ambad, Neha Bhatt, Roshan Kumar Jha · 2022 · International Journal of Health Sciences
  4. Insights into Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Gabriel Scarlat, Bassil Dona, Mihai Cârstea, Marilena Stoian · 2022 · Internal Medicine
  5. Faculty Opinions recommendation of Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research.
    Stefano Bellentani, Natalia Rosso · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  6. Modern aspects of pathogenesis of comorbidity of non-alcoholic fatty liver disease and hypertension in the presence or absence of chronic kidney disease.
    Kostyantyn Prosolenko, Kateryna Lapshyna, V.V. Ryabuha · 2022 · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini
  7. Cancer Care and Psychosocial Needs
    Saima Khursheed Beigh, Hira Gul · 2022 · Springer eBooks
  8. Clinical characteristics of hospitalized patients with metabolic-associated fatty liver disease–related liver cancer: data from a single center, 2010–2019
    Guishuang Wang, Hong Zhao, Lei Sun, Gang Wan, Wen Xie · 2023 · Therapeutic Advances in Chronic Disease
  9. Prevalencia, severidad y costes asociados al diagnóstico de pacientes con esteatosis hepática metabólica (EHmet)
    Natalia Mora Cuadrado · 2021
  10. NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES: MODERN IMAGING MODALITIES
    Alina Yu. Babenko, M. Yu. Laevskaya, Мелтонян Ася Робертовна, Савченков Юрий Николаевич, Г. Е. Труфанов · 2023 · Translational Medicine
  11. Development of a novel diagnostic model to monitor the progression of metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma in females
    Xiaoning Gan, Yun Zhou, Y F Li, Lin Xu, Guolong Liu · 2024 · Discover Oncology
  12. Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease
    Lihui Zhang, Sutong Liu, Qing Zhao, Xiao-Yan Liu, Tong Liu, Qiang Zhang, Ming-Hao Liu, Wenxia Zhao · 2025 · World Journal of Hepatology
  13. Metabolic-associated steatotic liver disease (MASLD): how I evolved my approach to diagnosis and staging
    Maria Kalafateli, Burcu Sena Aydin, Boran Polat, Michael S. Yee, Roberta Forlano, Chioma N. Izzi‐Engbeaya, Mark R. Thursz, Benjamin Harvey Mullish, Pinelopi Manousou · 2025 · Frontline Gastroenterology
  14. MASLD-Related HCC: Trends, Pathogenesis and Current Treatment Options
    Feng Li, Yizhong Wu · 2025 · Advances in Precision Medicine
  15. Prevention of HCC
    Ashraf Mohammad Al-Breedy, Mohamed Kamal Shaker, Medhat Elsahhar · 2025 · Springer eBooks
  16. Metabolic dysfunction-associated steatotic liver disease in metabolic syndrome
    Oksana M. Drapkina, Sergey Vladimirovich Nedogoda · 2025 · Russian Journal of Cardiology
  17. Foie métabolique
    Antonio Saviano, Lawrence Serfaty · 2025 · EMC - Hépatologie
  18. Highlighting the relevance of a multidisciplinary approach in metabolic-asociated steatotic liver disease (MASLD)
    Carmen Lara‐Romero, Miguel Angel Fernández-Gómez, Franz Martı́n, Luis Castilla‐Guerra, Jesús Funuyet‐Salas, Genoveva Berná, Raquel Millán-Domínguez, Manuel Romero‐Gómez · 2025 · Expert Review of Gastroenterology & Hepatology
  19. Additional file 2 of Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages
    He, Weiwei, Huang, Yinxiang, Shi, Xiulin, Wang, Qingxuan, Wu, Menghua, Li, Han, Liu, Qiuhong, Zhang, Xiaofang, Caoxin Huang, Li, Xuejun · 2023 · Figshare
  20. Additional file 1 of A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test
    Hou, Xiaoyu, Guan, Yunpeng, Yong Tang, Song, An, Zhao, Jiajun, 任路平, SHUCHUN CHEN, Wei, Limin, Ma, Huijuan, Song, Guangyao · 2021 · Figshare
  21. Additional file 1 of Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease Study
    Li, Ziyi, Na Yang, He, Liyun, Wang, Jialu, Ping, Fan, Wei Li, Xu, Lingling, Zhang, Huabing, Yuxiu Li · 2023 · Figshare
  22. Additional file 1 of Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages
    He, Weiwei, Huang, Yinxiang, Shi, Xiulin, Wang, Qingxuan, Wu, Menghua, Li, Han, Liu, Qiuhong, Zhang, Xiaofang, Caoxin Huang, Li, Xuejun · 2023 · Figshare
  23. Yin Yang Interactomes Drive the Metabolic Dysfunction-Associated Liver Disease Continuum to Hepatocellular Carcinoma
    Tyler L. Bissoondial, Ravi Reddi, Sita Sirisha Madugula, Manisha Shukla, Mahesh Narayan, Prakash Narayan A · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Rôle de Programmed cell Death-Ligand 1 dans la progression du carcinome hépatocellulaire
    Benoı̂t Rousseau · 2021
  25. Stéatopathie métabolique et carcinome hépatocellulaire : prédiction de la carcinogenèse à la réponse au traitement par profilage protéomique
    Adèle Delamarre · 2024
  26. Transcriptomics Analysis Reveals Dual Axes of Metabolic and Immune Dysregulation in the Progression of NAFLD to HCC
    Anusha Patodia, Harikeshav Karthik, Sulagna Basu, Varshini Venkatesan, Rakesh Pandey, Gowri Manohari Balachander · 2026 · Natural Sciences
  27. Prevention, surveillance, and early detection of hepatocellular carcinoma – a Brazilian multidisciplinary consensus
    Felipe José Fernández Coimbra, André Luís de Godoy, Paulo Henrique de Sousa Fernandes, Heládio Feitosa e Castro Neto, Rodrigo Nascimento Pinheiro, Ilka de Fátima Santana Ferreira Boin, Wellington Andraus, Francisco Tustumi, Paulo Cezar G AMARAL, Carlos Eduardo Brandão‐Mello et al. · 2026 · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
  28. Risk Prediction of Early‐Onset Hepatocellular Carcinoma: Derivation and Validation in a Nationwide Young Adult Cohort
    Seogsong Jeong, Gi‐Ae Kim, Heejoon Jang, D Lee, Sae Kyung Joo, Keon Wook Kang, Hwamin Lee, Won Kyum Kim · 2026 · Alimentary Pharmacology & Therapeutics
  29. A bibliometric analysis of hepatocellular carcinoma screening in high risk populations
    Chengdian Lan, Dan-Lan Lian, Cui-Ling Huang · 2026 · Discover Oncology
  30. GLP-1 receptor agonists at the crossroads of diabetes, hepatic steatosis, and hepatocellular carcinoma
    Alfredo Vozza, Filippo Biagi, Raggi Chiara, Francesco Vizzutti, Fabio Marra · 2026 · Internal and Emergency Medicine
  31. Chronic bisphenol A exposure at LOAEL induces hepatic metabolic remodeling associated with NAFLD-related pathways and hepatocarcinogenic susceptibility
    Ewa Lepiarczyk, Marta Wiszpolska, Mateusz A. Maździarz, Krystyna Makowska, Sławomir Gonkowski, Jerzy Kaleczyc, Marta Majewska · 2026 · Metabolomics
  32. Environmental factors related to pathogenesis of hepatocellular carcinoma
    Li-Baihe Jing, Yumin Li · 2026 · Hepatobiliary & pancreatic diseases international
  33. Molecular smugglers in obesity-driven MASLD: Snitching on adipose-derived extracellular vesicles
    Qiuyang Chen, Taisiia Shevchenko, Dewen Zhan, Ningning Ma, Sander Lefere, Joost Boeckmans, Joery De Kock, Freddy Van Goethem, Yong He, Tamara Vanhaecke et al. · 2026 · Acta Pharmaceutica Sinica B
  34. Long non-coding RNA LINC00885 contributes to liver steatosis through modulation of DHRS2-associated lipid metabolic programs
    Kuei‐Yen Tsai, Po‐Li Wei, Kang‐Yi Su, Cheng-Chin Lee, Uyanga Batzorig, Chien-Yu Huang, Yujia Chang · 2026 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  35. Metabolic Dysfunction‐Associated Steatotic Liver Disease
    Fasiha Kanwal, Vincent Wai Sun Wong · 2026 · Wiley eBooks
  36. Noninvasive Diagnosis of Hepatocellular Carcinoma Outside Guideline-Defined High-Risk Populations: Evolving Perspectives in the Era of MASLD
    Tae Wook Kang, Byeong Geun Song · 2026 · Korean Journal of Radiology